Certified by Founder Lodge
Maxion Therapeutics
United Kingdom - Cambridge START UP
1 Disclosed Funding Rounds $16,000,000
0 Participating Investments
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 21 ,2023 | Series A | $16,000,000 | |
| March, 18 ,2025 | Series A | $72,000,000.00 | |
| March, 18 ,2025 | Series A | $72,000,000.00 |
BGF
LifeArc Ventures
Monograph Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Further AI | $5,000,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
